WNT5A and breast neoplasm: Interestingly, in a recent study from our lab, WNT5A and its mimic Foxy5 has been shown to reduce breast cancer cell migration even in the presence of high lactate levels, suggesting its therapeutic potential in managing highly glycolytic breast tumors as well.